Hjem › Meningiom › Massachusetts
Meningiom kliniske forsøg i Massachusetts
6 studier for Meningiom søger deltagere på steder i Massachusetts.
Byer i Massachusetts
Officiel studietekst (engelsk)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- Dana-Farber/Harvard Cancer Center, Boston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06955169A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Massachusetts General Hospital, Boston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT07428616Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- Massachusetts General Hospital, Boston
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT04374305A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
- Mass General, Boston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. jul. 2026 · NCT07533942Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Beth Israel Deaconess Medical Center, Boston
- Beth Israel Deaconess Medical Center, Boston
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 22. jul. 2026 · NCT04427384Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.